ResMed Inc.
RSMDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40 | $38 | $33 | $34 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $40 | $37 | $33 | $34 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -0.9% | 4.4% | 0.8% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 61.5% | 60.8% | 59.3% | 58.6% |
| EBITDA | $1 | $1 | $0 | $0 |
| % Margin | 37.7% | 39.5% | 36.4% | 37.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 26.1% | 28.2% | 28.3% | 26.9% |
| EPS Diluted | 2.37 | 2.58 | 2.48 | 2.34 |
| % Growth | -8.1% | 4% | 6% | – |
| Operating Cash Flow | $0 | $1 | $1 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $1 | $1 | $0 |